C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2002
12/27/2002	WO2002102780A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient
12/27/2002	WO2002102778A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/27/2002	WO2002102376A1 ORALLY DELIVERABLE PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE COMPOUND HAVING AN AMINOSULFONYL GROUP (cox-2 INHIBITOR), A POLYETHYLENE GLYCOL AND A FREE-RADICAL SCAVENGING ANTIOXIDANT
12/27/2002	WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
12/27/2002	WO2002009758A3 Inhibitors of cellular efflux pumps of microbes
12/27/2002	CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	CA2446963A1 Quinazolinediones as antibacterial agents
12/27/2002	CA2446931A1 Pyrrolidine bicyclic compounds
12/27/2002	CA2444356A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant
12/27/2002	CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/27/2002	CA2422745A1 Novel bicyclic isoxazolinones as antibacterial agents
12/26/2002	US20020198245 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002	US20020198244 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002	US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002	US20020198232 4-substituted quinoline derivatives
12/26/2002	US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents
12/26/2002	US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002	US20020198197 Metabotropic glutamate receptor agonist for treatment or prevention of acute and/or chronic neurological disorders
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines
12/25/2002	CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002	CN1387513A Positive modulators of nicotinic receptor agonists
12/25/2002	CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/25/2002	CN1097050C Substd 2,4-imidazolidinedione compounds and pharmaceutical active ingredients
12/25/2002	CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/25/2002	CN1097044C Taxane derivs. and drugs contg. same
12/24/2002	US6498255 Cholinesterase inhibitors; cognition activators; alzheimer's disease; e.g., 3-(2-(1-(phenylmethyl)-4-piperidinyl)ethyl)-1,2-benzisoxazole
12/24/2002	US6498185 Enzyme factor xa inhibitors
12/24/2002	US6498179 Such as 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl)-2-(2-methyl-1 -imidazolyl)oxazole; insulin secertion promoting and blood sugar depressing effect; diabetes; low toxicity
12/24/2002	US6498178 Inhibitors of IMPDH enzyme
12/24/2002	US6498174 Agonists to peroxisome proliferator-activated receptors; modulating blood glucose and lipid levels; reducing dyslipidemia and hyperinsulinemia associated with impaired glucose tolerance or metabolic syndrome
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis
12/24/2002	US6498158 Il-5 inhibiting 6-azauracil derivatives
12/24/2002	US6498125 Pyridine ketones useful as herbicides
12/24/2002	US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/24/2002	US6497730 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibers, dyeing compositions and methods
12/24/2002	CA2054339C 3-amidoindolyl derivatives
12/19/2002	WO2002101073A2 Aryl-benzimidazole compounds having antiinfective activity
12/19/2002	WO2002101007A2 Antipathogenic benzamide compounds
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100856A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	WO2002100855A1 Method of mycophenolate mofetil preparation
12/19/2002	WO2002100852A1 Benzothiophene compounds having antiinfective activity
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100835A1 Heterocyclic compounds having antitumor activity
12/19/2002	WO2002100832A1 Isoquinoline compounds having antiinfective activity
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	WO2002100818A2 Aminediols as agents for the treatment of alzheimer's disease
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100486A1 Method and apparatus for treating uterine myoma
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100399A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002070541A3 Peptide deformylase inhibitors
12/19/2002	WO2002063957A3 Selective substituted aryl ketone and safener based herbicides
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	WO2002050082A3 Inhibitors of papilloma virus
12/19/2002	WO2001047919A9 Substituted oxazolidinones and their use in the field of blood coagulation
12/19/2002	WO2000058303A9 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193597 3-(heteroarylamino) indazole, 1,2-benzisothiazole, or 1,2-benzisoxazole derivatives of given formula; for treating nervous system disorders such as pain, anxiety and bipolar disorder
12/19/2002	US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002	US20020193407 Modulators of CCR5 chemokine receptor activity
12/19/2002	US20020193382 Sulfonamide derivatives, their production and use
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002	US20020193367 Dihydro-benzo [b] [1,4] diazepin-2-one derivatives
12/19/2002	US20020193361 For therapy of cancer and other conditions characterized by abnormal cellular proliferation
12/19/2002	CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002	CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450205A1 Aminediols for the treatment of alzheimer's disease
12/19/2002	CA2450202A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	CA2450167A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	CA2450013A1 Method of mycophenolate mofetil preparation
12/19/2002	CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	CA2449544A1 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/18/2002	EP1266897A2 Hypoglycemic imidazoline compounds
12/18/2002	EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them
12/18/2002	EP1266651A2 UV absorbing and photostabilizing agents and compositions and external preparation for skin
12/18/2002	EP1265902A1 Method for producing sulfonyl imidazole derivatives by phase transfer catalysis
12/18/2002	EP1265873A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
12/18/2002	EP1265872A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
12/18/2002	EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002	EP0869949B1 Benzoxazine antimicrobial agents
12/18/2002	EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same

1 ... 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 ... 647